Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Organisation › Details

ERS Genomics Ltd.

ERS Genomics was formed to commercialise the foundational CRISPR-Cas9 intellectual property held by Dr. Emmanuelle Charpentier. Licenses are available for research and sale of products and services across multiple fields including: research tools, kits, reagents; discovery of novel targets for therapeutic intervention; cell lines for discovery and screening of novel drug candidates; GMP production of healthcare products; production of industrial materials such as enzymes, biofuels and chemicals; and synthetic biology. *

 

Period Start 2014-02-17 established
Products Industry CRISPR gene editing technology
  Industry 2 IP services
Persons Person Rhodes, Eric (ERS Genomics 201606– CEO before Horizon Discovery since 201201 before Sigma-Aldrich + Sangamo Biosciences)
  Person 2 Charpentier, Emmanuelle (Helmholtz 201412 Professor at HZI)
     
  Street 88 Harcourt Street
  City Dublin 2
    Address record changed: 2016-05-22
     
Basic data Employees n. a.
     
    * Document for �About Section�: Bayer AG. (5/17/16). "Press Release: Bayer and ERS Genomics Announce Licensing Agreement for Genome Editing Patents". Leverkusen & Dublin.
     
   
Record changed: 2018-10-31

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

More documents for ERS Genomics Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top